Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Weber, Marianne F ^a   Cunich, Michelle ^b   Smith, David P ^a   Salkeld, Glenn ^b   Sitas, Freddy ^a   O'Connell, Dianne ^a,b,c,d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cancer screening; Faecal occult blood test; Mammography; Prostate specific antigen test; Sociodemographic characteristics; Socioeconomic status

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; AUSTRALIA; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HUMAN; MALE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM; OCCULT BLOOD; QUESTIONNAIRE; SELF REPORT; SOCIOECONOMICS; UTILIZATION REVIEW;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASMS; NEW SOUTH WALES; OCCULT BLOOD; PROSTATE-SPECIFIC ANTIGEN; QUESTIONNAIRES; SELF REPORT; SOCIOECONOMIC FACTORS;

EID: 84876972572     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-429     Document Type: Article

References (59)

1. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012, Cancer in Australia: an overview, 2012. Cancer series no. 74. Cat. no. CAN 70 Canberra: AIHW 2012
2. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Mandel JS, Church TR, Ederer F, Bond JH, J Natl Cancer Inst 1999 91 434 437 10.1093/jnci/91.5.434 10070942 (Pubitemid 29128279)
3. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG, J Natl Cancer Inst 1993 85 1311 1318 10.1093/jnci/85.16.1311 8340943 (Pubitemid 23249723)
4. Long-term effects of mammography screening: updated overview of the swedish randomised trials. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE, Lancet 2002 359 909 919 10.1016/S0140-6736(02) 08020-0 11918907 (Pubitemid 34246378)
5. Screening for prostate cancer: U.S. Preventive services task force recommendation statement. Moyer VA, Ann Intern Med 2012 157 120 134 10.7326/0003-4819-157-2-201207170-00459 22801674
6. Australian Health Technology Advisory Committee, Prostate cancer screening Canberra: Commonwealth Department of Health and Family Services 1996
7. 'A Matter of faith, not science': analysis of media coverage of prostate cancer screening in australian news media 2003-2006. MacKenzie R, Chapman S, Holding S, McGeechan K, J R Soc Med 2007 100 513 521 10.1258/jrsm.100.11.513 18048709 (Pubitemid 350273404)
8. Prostate cancer and prostate-specific antigen testing in New south wales. Smith DP, Supramaniam R, Marshall VR, Armstrong BK, Med J Aust 2008 189 315 318 18803534
9. Australian Institute of Health and Welfare, BreastScreen australia monitoring report 2009-2010. Cancer series no. 72. Cat. no. CAN 68 Canberra: AIHW 2012
10. Department of Health, Victorian population health survey Melbourne, Victoria: Department of Health 2008
11. Targeting services to reduce social inequalities in utilisation: an analysis of breast cancer screening in New south wales. Birch S, Haas M, Savage E, Van Gool K, Aust New Zealand Health Policy 2007 4 12 10.1186/1743-8462-4-12 17550622 (Pubitemid 46993297)
12. Australian Institute of Health and Welfare, National bowel cancer screening program monitoring report: phase 2, july 2008- june 2011. Cancer series no. 65. Cat. no. CAN 61 Canberra: AIHW 2012
13. Men in australia telephone survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older australian men. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, Handelsman DJ, de Kretser DM, Lancet 2005 366 218 224 10.1016/S0140-6736(05)66911-5 16023512 (Pubitemid 40981049)
14. Urban-rural differences in prostate cancer outcomes in australia: what has changed? Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK, Medical Journal of Australia 2011 194 293 296 21426283
15. Equity of colorectal cancer screening: cross-sectional analysis of national bowel cancer screening program data for south australia. Ward PR, Javanparast S, Matt MA, Martini A, Tsourtos G, Cole S, Gill T, Aylward P, Baratiny G, Jiwa M, Aust N Z J Public Health 2011 35 61 65 10.1111/j.1753-6405. 2010.00637.x 21299702
16. Who has regular mammograms? effects of knowledge, beliefs, socioeconomic status, and health-related factors. Achat H, Close G, Taylor R, Prev Med 2005 41 312 320 10.1016/j.ypmed.2004.11.016 15917027 (Pubitemid 40755095)
17. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G, BMC Public Health 2011 11 38 10.1186/1471-2458-11-38 21232156
18. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Weller D, Pinnock C, Silagy C, Hiller JE, Marshall VR, Aust N Z J Public Health 1998 22 400 402 10.1111/j.1467-842X.1998.tb01400.x 9629831 (Pubitemid 28253954)
19. Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J, Aust N Z J Public Health 2002 26 236 241 10.1111/j.1467-842X.2002.tb00680.x 12141619 (Pubitemid 35446372)
20. Data and trends in cancer screening in the united states: results from the 2005 national health interview survey. Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, Ballard-Barbash R, Cancer 2010 116 4872 4881 10.1002/cncr.25215 20597133
21. Behavioral associations between prostate and colon cancer screening. Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ, J Am Coll Surg 2005 200 216 223 10.1016/j.jamcollsurg.2004.10.015 15664097 (Pubitemid 40143213)
22. Associations in breast and colon cancer screening behavior in women. Carlos RC, Fendrick AM, Patterson SK, Bernstein SJ, Acad Radiol 2005 12 451 458 10.1016/j.acra.2004.12.024 15831418
23. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? Carlos RC, Fendrick AM, Ellis J, Bernstein SJ, J Am Coll Radiol 2004 1 769 776 10.1016/j.jacr.2004.05.018 17411698 (Pubitemid 40357854)
24. Progress in cancer screening practices in the united states: results from the 2000 national health interview survey. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC, Cancer 2003 97 1528 1540 10.1002/cncr.11208 12627518 (Pubitemid 36297783)
25. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L, Am J Public Health 2001 91 1264 1272 10.2105/AJPH.91.8.1264 11499116 (Pubitemid 32708867)
26. Cancer screening in queensland men. Carriere P, Baade P, Newman B, Aitken J, Janda M, Med J Aust 2007 186 404 407 17437394 (Pubitemid 46691860)
27. Completion of colorectal cancer screening in women attending screening mammography. Molina L, Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Bernstein SJ, Acad Radiol 2004 11 1237 1241 10.1016/j.acra.2004.07.025 15561570
28. Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment? Red SN, Kassan EC, Williams RM, Penek S, Lynch J, Ahaghotu C, Taylor KL, Cancer 2010 116 4703 4710 10.1002/cncr.25229 20578178
29. Correlates of colorectal cancer screening adherence among Men Who have been screened for prostate cancer. Wong YN, Coups EJ, J Cancer Educ 2011 26 301 307 10.1007/s13187-011-0194-2 21360029
30. Population characteristics related to colorectal cancer testing in New south wales, australia: results from the 45 and Up study cohort. Weber MF, Banks E, Ward R, Sitas F, J Med Screen 2008 15 137 142 10.1258/jms.2008.008050 18927096
31. Cohort profile: the 45 and up study. Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, Beral V, Byles J, Corbett S, Cumming R, Int J Epidemiol 2008 37 941 947 17881411
32. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD, BMC Med Res Methodol 2010 10 26 10.1186/1471-2288-10-26 20356408
33. The early detection of prostate cancer in general practice: supporting patient choice http://www.usanz.org.au/uploads/29168/ufiles/ 6%20%20PSA%20decision%20card%20041007.pdf
34. Medical benefits schedule statistics http://www.medicareaustralia.gov.au/ provider/medicare/mbs.jsp#N1003F
35. Australian Bureau of Statistics, Household income and income distribution 2009-10. Cat No. 6523.0 Canberra: ABS 2011 23688439
36. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, Walters EE, Zaslavsky AM, Psychol Med 2002 32 959 976 10.1017/S0033291702006074 12214795
37. Australian Bureau of Statistics, Census of population and housing Canberra: Commonwealth of Australia 2006
38. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Nickson C, Mason KE, English DR, Kavanagh AM, Cancer Epidemiol Biomarkers Prev 2012 21 1479 1488 10.1158/1055-9965.EPI-12-0468 22956730
39. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Gattellari M, Ward JE, Patient Educ Couns 2005 57 168 182 10.1016/j.pec.2004.05.011 15911190 (Pubitemid 40724373)
40. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. Cullati S, Charvet-Berard AI, Perneger TV, BMC Public Health 2009 9 118 10.1186/1471-2458-9-118 19402895
41. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Wardle J, McCaffery K, Nadel M, Atkin W, Soc Sci Med 2004 59 249 261 10.1016/j.socscimed.2003.10.030 15110417 (Pubitemid 38534255)
42. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries (AACR), Cancer survival in Australia 1992-1997: geographic categories and socioeconomic status. AIHW cat. no. CAN 17 Canberra: Australian Institute of Health and Welfare (Cancer Series no. 22) 2003 23228588
43. Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Armstrong BK, Cancer survival, incidence and mortality by area health service in NSW 1994 to 2000 Sydney: Cancer Council NSW 2003
44. Predictors of non-attendance for second round mammography in an australian mammographic screening programme. O'Byrne AM, Kavanagh AM, Ugoni A, Diver F, J Med Screen 2000 7 190 194 10.1136/jms.7.4.190 11202585 (Pubitemid 32099056)
45. Change and adjustment in rural victoria. Presentation to the 13th ministerial rural and regional health forum, 17 august 2007 http://www.health. vic.gov.au/ruralhealth/downloads/phillips-dpi.pdf
46. The association between social networks and colorectal cancer screening in american males and females: data from the 2005 health information national trends survey. Ye J, Williams SD, Xu Z, Cancer Causes & Control: CCC 2009 20 1227 1233 10.1007/s10552-009-9335-x 23696903
47. Influences on participation in a community-based colorectal neoplasia screening program by virtual colonoscopy in australia. Forbes GM, Fritschi L, Mendelson RM, Foster NM, Edwards JT, Aust N Z J Public Health 2004 28 283 287 15707176 (Pubitemid 38868325)
48. Colorectal cancer screening with faecal occult blood testing: community intention, knowledge, beliefs and behaviour. Tong S, Hughes K, Oldenburg BB, Mar CD, Asia Pac J Public Health 2006 18 16 23 10.1177/10105395060180010401 16629434
49. Predictors of colorectal cancer screening participation in the united states. Ioannou GN, Chapko MK, Dominitz JA, Am J Gastroenterol 2003 98 2082 2091 10.1111/j.1572-0241.2003.07574.x 14499792 (Pubitemid 37185810)
50. Trends in prostate-specific antigen test use, 2000-2005. Ross LE, Taylor YJ, Howard DL, Public Health Rep 2011 126 228 239 21387953
51. Predictors of non-attendance from BreastScreen NSW in women who report current mammography screening. Taylor R, Ivanov O, Page A, Brotherton J, Achat H, Close G, Aust N Z J Public Health 2003 27 581 587 10.1111/j.1467-842X.2003. tb00603.x 14723404 (Pubitemid 38028647)
52. Knowledge, attitude and intentions related to colorectal cancer screening using faecal occult blood tests in a rural australian population. Janda M, Stanton WR, Hughes K, Del Mar C, Clavarino A, Aitken JF, Tong S, Short L, Leggett B, Newman B, Asia Pac J Public Health 2003 15 50 56 10.1177/ 101053950301500109 14620498 (Pubitemid 37378773)
53. Mammography screening participation: effects of a media campaign targeting italian-speaking women. Page A, Morrell S, Tewson R, Taylor R, Brassil A, Aust N Z J Public Health 2005 29 365 371 10.1111/j.1467-842X.2005.tb00208.x 16222935 (Pubitemid 41670839)
54. Prostate cancer testing: behaviour, motivation and attitudes among western australian men. Slevin TJ, Donnelly N, Clarkson JP, English DR, Ward JE, Med J Aust 1999 171 185 188 10494233 (Pubitemid 29392790)
55. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Cole SR, Young GP, Byrne D, Guy JR, Morcom J, J Med Screen 2002 9 147 152 10.1136/jms.9.4.147 12518003 (Pubitemid 36135339)
56. Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening. Salkeld GP, Solomon MJ, Short L, Ward J, ANZ J Surg 2003 73 128 132 10.1046/j.1445-2197.2003.02650.x 12608975 (Pubitemid 36513097)
57. Accuracy of self-reported cancer-screening histories: a meta-analysis. Rauscher GH, Johnson TP, Cho YI, Walk JA, Cancer Epidemiol Biomarkers Prev 2008 17 748 757 10.1158/1055-9965.EPI-07-2629 18381468 (Pubitemid 351536402)
58. Breslow NE, Day N, Statistical methods in cancer research. Volume II- The design and analysis of cohort studies. IARC scientific publication No 82 International Agency for Research on Cancer: Lyon, France 1987
59. Merging and emerging cohorts: not worth the wait. Willett WC, Blot WJ, Colditz GA, Folsom AR, Henderson BE, Stampfer MJ, Nature 2007 445 257 258 10.1038/445257a 17230171 (Pubitemid 46122799)